Members

The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.

The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.

Apply Now Learn More View Core Group

Current Members


Name Organizationsort descending Country
Heinz Moser Achaogen United States
Kolawole Ekanoye Advocates for Health and Development Initiative Nigeria
Ann Ginsberg Aeras United States
Joan A. Cayla Agència de Salut Pública de Barcelona Spain
Ahmadul Khan Ahmadul Hasan Khan Bangladesh
Hiromu Kawakubo Asahi Kasei Chemicals Corporation Japan
Barry Furr Astrazeneca United States
Robert Wallis Aurum Institute South Africa
Gary Horwith BARDA United States
Simon Tiberi Barts Healthcare NHS Trust United Kingdom
Christopher Locher Baxalta United States
Martin Springsklee Bayer Healthcare United States
Jan Gheuens Bill & Melinda Gates Foundation United States
Ken Duncan Bill & Melinda Gates Foundation United States
Cathy Bansbach Bill & Melinda Gates Foundation United States
Gilla Kaplan Bill & Melinda Gates Foundation United States
Omar Vandal Bill and Melinda Gates Foundation United States
Peter Warner Bill and Melinda Gates Foundation United States
Yadav Prasad Joshi Biodyss and Journal Infection in Developing Countries France
Marc Gitzinger BioVersys AG Switzerland
Juan David Guzman Birkbeck College United Kingdom
C. Robert Horsburgh Boston University School of Public Health United States
Shashank Gupta Brown University United States
Jerome Zeldis Celgene United States
Benson Muriuki Center for the Empowerment Of The Local Herbalist-Celoh Kenya Kenya
Sidharth Chopra Central Drug Research Institute, Lucknow India
Martin Dolezal Charles University in Prague, Faculty of Pharmacy in Hradec Kralove Czech Republic
Robert Husson Children's Hospital Boston/Harvard Medical School United States
Masaji Okada Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center Japan
Shreemanta Parida Clinical Scientist India
Regina Osih Clinton Health Access Initiative South Africa
Barry Bunin Collaborative Drug Discovery United States
Ian Orme Colorado State University United States
Anne Lenaerts Colorado State University United States
Mary Jackson Colorado State University United States
Mary Ann de Groote Colorado State University United States
Diane Ordway Colorado State University United States
Josef Jampilek Comenius University Slovakia
Albert Makone Community Representative; Global Fund (local) Zimbabwe
Brian VanderVen Cornell University United States
David Russell Cornell University United States
Boitumelo Semete Council of Scientific Industrial Research (CSIR) in South Africa South Africa
Hulda Swai Council of Scientific Industrial Research (CSIR) in South Africa South Africa
Debra Hanna CPTR, Critical Path Institute United States
Ravishankar Ramachandran CSIR-Central Drug Research Institute, Lucknow, India India
Tanjore Balganesh CSIR-OSDD India
Anneke Hesseling Desmond Tutu TB Centre South Africa
Todd Waldman Easton Associates United States
Stewart Cole École Polytechnique Fédérale de Lausanne (EPFL) Switzerland
Neeraj Dhar École Polytechnique Fédérale de Lausanne (EPFL) Switzerland
Philip Hipskind Eli Lilly and Company; Lilly Research Laboratories United States
Kenneth Castro Emory University United States
Yap Boum II Epicentre/MSF Uganda
Jurriaan de Steenwinkel Erasmus MC Netherlands
Wim Vandevelde European AIDS Treatment Group (EATG); Community Representative South Africa
Carol Dukes Hamilton Family Health International United States
Rick O'Brien Foundation for Innovative New Diagnostics Switzerland
Xuelian Zhang Fudan University China
Doug Lowrie Fudan University's Shanghai Public Health Clinical Center China
Mohammad Hassan Mashori Fundamental Human Rights & Rural Development Association (FHRRDA) Pakistan
Nii Nortey Hanson-Nortey Ghana Health Service Ghana
David Barros GlaxoSithKline Spain
Robert Bates GlaxoSmithKline Spain
Oscar Della Pasqua GlaxoSmithKline United Kingdom
Lluís Ballell GlaxoSmithKline Tres Cantos Spain
Christopher Cooper Global Alliance for TB Drug Development (TB Alliance) United States
Stephen Matlin Global Forum for Health Research Switzerland
Bonita Mangura Global TB Institute at UMDNJ United States
Samir Roy Government Medical College, Bhavnagar India
Muhammad Farooq Government of Pakistan Pakistan
Alick Chimpimo Makiyi Grassroots Movement for Health and Development (GMHD) Malawi
Carole Mitnick Harvard Medical School United States
Matthew Price Harvard School of Public Health United States
Polly Clayden HIV i-Base United Kingdom
James Frincke Hollis Eden Pharmaceuticals United States
Brian Robertson Imperial College London United Kingdom
Tanya Parish Infectious Disease Research Institute (IDRI) United States
Allen Casey Infectious Disease Research Institute (IDRI) United States
Iain Old Innovative Medicines for TB (iM4TB) Switzerland
Pere-Joan Cardona Institut Germans Trias i Pujol (IGTP) Spain
Nicolas Willand Institut Pasteur Lille France
Kevin Pethe Institut Pasteur-Korea South Korea
Scott Franzblau Institute for Tuberculosis Research, University of Illinois at Chicago United States
Hugo Cesar Gramajo Instituto de Biologia Molecular y Celular de Rosario Argentina
Kanury Rao International Centre for Genetic Engineering & Biotechnology-New Delhi India
Dorothy Odhiambo International Community of Women Living with HIV in Kenya ( ICW-K) Kenya
Chris Edlin iThemba Pharmaceuticals South Africa
Roger Moses iThemba Pharmaceuticals United Kingdom
Koen Andries Janssen Belgium
Tado Shimao Japan Anti-Tuberculosis Association (JATA) Research Institute of TB Japan
Noroi Doi Japan Anti-Tuberculosis Association (JATA) Research Institute of TB Japan
William Bishai Johns Hopkins School of Medicine United States
Eric Nuermberger Johns Hopkins University United States
Ying Zhang Johns Hopkins University United States
Gyanu Lamichhane Johns Hopkins University United States
Richard Chaisson Johns Hopkins University Center for TB Research United States
Petros Karakousis Johns Hopkins University School of Medicine United States
Shichun Lun Johns Hopkins University School of Medicine United States
Anil Koul Johnson and Johnson Belgium
Sergey Koren JSC Pharmasyntez Russia
Oren Zimhony Kaplan Medical Center, The School of Medicine Hebrew University Israel
Steve Wandiga KEMRI/CDC Kenya
Martin Graham KinderPharm United States
James Love Knowledge Ecology International (KEI) United States
Sang Jae Kim Korean Institute of Tuberculosis South Korea
Maria Freire Lasker Foundation United States
Richard White London School of Hygiene and Tropical Medicine United Kingdom
Michael Hoelscher Ludwig-Maximilians-University Germany
Galyna Kutsyna Luhansk State Medical University Ukraine
Rajender Kamboj Lupin Limited India
Prasit Palittapongarnpim Mahidol University Thailand
Renaud Boulanger McGill University Canada
David McNeeley Medical Service Corportation International (MSCI) United States
Tarek Aboul-Fadl Medicinal Chemistry, Assiut University Egypt
Maggie McCammon Michigan Economic Development Corporation United States
Dhanji Rajani Microcare Laboratory India
Sonja Henne MSF Tunisia
Asaad Khalid Ahmed National Center for Research Sudan
Nino Lomtadze National Center for Tuberculosis and Lung Diseases Georgia
Nelly Solomonia National Center for Tuberculosis and Lung Diseases Georgia
Shekhar Mande National Centre for Cell Science India
Barbara Laughon National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Jim Boyce National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Laura Via National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Francisco Leyva National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Sharon Williams National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Christine Sizemore National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Gail Tauscher National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Mamodikoe Makhene National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Marina Protopopova National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Jing Bao National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Clifton Barry National Institute for Allergy and Infectious Diseases (NIH/NIAID) United States
Rogelio Hernandez Pando National Institute of Medical Sciences and Nutrition, Mexico Mexico
Liyanage Perera National Institutes of Health (NIH) United States
Helena Boshoff National Institutes of Health (NIH) United States
Andriy Dudnyk National Medical University of Vinnytsia, Ukraine Ukraine
Basharat Khan National TB Control Programme Pakistan
Zahoor Ahmed National TB Control Programme Pakistan
Htay Lwin National TB Program, Myanmar Myanmar (Burma)
Abdifetah Ibrahim Omer National TB Programme Somalia Somalia
Thomas Dick National University of Singapore Singapore
Daniela Jabes NeED Parma Italy
Roberto Salvino No affiliation Philippines
Sandeep Saluja No affiliation India
Avishek Anant Novartis India
Manjunatha Ujjini Novartis Institute for Tropical Diseases Singapore
Lawrence Geiter Otsuka Pharmaceutical Company United States
Martin Johan Boeree PanACEA Consortium and the Radboud University Nijmegen Medical Centre Netherlands
Edward Nardell Partners in Health United States
Valerie Flore Donkeng Donfack Pasteur Center in Cameroon Cameroon
Claire Wingfield PATH United States
Chris Dippel Peloton Partnering, SP United States
Nelson Otwoma Positive Familes Network (+FN) Kenya
Teto Fondacaro Mamona Programme National de Lutte Contre la Tuberculose Democratic Republic Of Congo (Zaire)
Khadar Bhatcha PSG College of Pharmacy India
Daniel Zollinger QareFree Netherlands
Dario Scaramuzzi R-Evolution Group EEIG Italy
Bolin Geng Ra Pharma United States
Bob Goldman RCG Consulting United States
Michaela Nielsen Regulatory Affairs Consultant United States
Santiago Ramón García Research Agency of Aragon (ARAID) Spain
Gail Cassell Research America United States
Doris Rouse RTI International United States
Isabelle Cieren-Puiseux Sanofi France
Charles Wells Sanofi United States
Didier Leboulleux Sanofi France
Brigitte Demers Sanofi France
Florence Bordon-Pallier Sanofi France
Alexandra Carreau Sanofi-Adventis R&D France
John Szumowski Santa Clara Valley Medical Center United States
Victoria Kasprowicz SANTHE South Africa
Fernando Pavan Sao Paulo State University, UNESP, Brazil Brazil
Jacques Grosset Scientist France
Carol Nacy Sequella, Inc. United States
Leo Einck Sequella, Inc. United States
Prasad Pasam Shar Technologies Group India
KR John SRM Medical College India
Dennis Mitchison St Georges. University of London United Kingdom
Amina Jindani St. George's, University of London United Kingdom
Gerhard Walzl Stellenbosch University South Africa
Edward Berry SUNY Upstate Medical University United States
Gill Black Sustainable Livelihoods Foundation South Africa
Klaus Reither Swiss Tropical and Public Health Institute Tanzania
Anna Upton TB Alliance United States
Takushi Kaneko TB Alliance United States
Rajneesh Taneja TB Alliance United States
Frances Pappas TB Alliance United States
Khisimuzi Mdluli TB Alliance United States
Christo van Niekerk TB Alliance South Africa
Melvin Spigelman TB Alliance United States
Cherise Scott TB Alliance United States
Asghar Arif TB Association Charsadda Pak Pakistan
Dalene von Delft TB Proof South Africa
Jeffery Cirillo Texas A&M Health Science Center United States
William Chamberlin Texas Tech University Health Sciences Center United States
Sanjib Bhakta The Institute of Structural and Molecular Biology, Birkbeck, University of London United Kingdom
Kristina Wallengren THINK South Africa
Erica Lessem Treatment Action Group United States
Mark Harrington Treatment Action Group United States
Ronan O'Toole Trinity College Dublin Ireland
P. R. Narayanan Tuberculosis Research Centre, Chennai (retired) India
Andrew Vernon U.S. Centers for Disease Control and Prevention (CDC) United States
Valerie Mizrahi UCT-Institute of Infectious Disease and Molecular Medicine South Africa
Joshua Wamboga Uganda Network of AIDS Service Organisations (UNASO) Uganda
Joel Freundlich UMDNJ - New Jersey Medical School United States
Amy Bloom United States Agency for International Development (USAID) United States
Aboubacar Sidiki Daffe Université Cheikh Anta DIOP Senegal
Ibrahim Abubakar University College London, MRC Clinical Trials Unit United Kingdom
Arun Kumar Mishra University of Birmingham United Kingdom
Yossef Av-Gay University of British Columbia Canada
Payam Nahid University of California, San Francisco United States
Jonathan Blackburn University of Cape Town South Africa
Ute Muh University of Iowa United States
Oleg Tsodikov University of Kentucky United States
Parameshwar Makam University of KwaZulu-Natal South Africa
Christopher Sassetti University of Massachusetts Medical School United States
Sylvie Garneau-Tsodikova University of Michigan United States
Anthony Baughn University of Minnesota United States
Bernard Fourie University of Pretoria South Africa
Marcio Dias University of Sao Paulo Brazil
Andreas Diacon University of Stellenbosch South Africa
Tawanda Gumbo University of Texas Southwestern Medical Center at Dallas United States
Bavesh Kana University of the Witwatersrand/National Health Laboratory Service South Africa
David Sherman University of Washington United States
Norbert Heinrich Universtiy of Munich / PanACEA Germany
Shashi Kant UT Southwestern Medical Center United States
Michael Cynamon VAMC, SUNY, Upstate Medical University United States
Tiansheng Wang Vertex Pharmaceuticals United States
Astrid Van der Sar VU University Medical Center Netherlands
Carl Nathan Weill Cornell Medical College United States
Dirk Schnappinger Weill Cornell Medical College United States
Kyu Rhee Weill Cornell Medical College United States
Tamari Trapaidze Welfare Foundation Georgia
Philip Onyebujoh WHO Regional Office for Africa Zimbabwe
Kobina Bosumtwi Dadzie Wiljok Childaid and Health Organization Ghana
Christian Lienhardt World Health Organization (WHO) Senegal
Malgosia Grzemska World Health Organization (WHO) Switzerland
Mario Raviglione World Health Organization (WHO) Switzerland
Sang Nae Cho Yonsei University College of Medicine South Korea
Kampasati Satyanarayana Yuvabharath Society India

New Members


The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.

Apply Now

Questions? Contact Us